Gene screenings hold disease clues, but unexplained anomalies often raise fears
Many genetic findings are ambiguous, leaving doctors uncertain about whether a particular variant is truly dangerous.
Many genetic findings are ambiguous, leaving doctors uncertain about whether a particular variant is truly dangerous.
Invitae's proposition with these new panels is to democratize the genetic panel screen - testing for deeply impactful disorders that stretch beyond cancer.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.